Because of a lapse in government funding, the information on this
website may not be up to date, transactions submitted via the
website may not be processed, and the agency may not be able to
respond to inquiries until appropriations are enacted. The NIH
Clinical Center (the research hospital of NIH) is open. For more
details about its operating status, please visit
cc.nih.gov. Updates
regarding government operating status and resumption of normal
operations can be found at
opm.gov.
Parkinson Disease, Secondary MeSH Descriptor Data 2026
/chem ind permitted: coord IM with drug /adv eff-pois-tox (IM); coord IM with other cause (IM)
Scope Note
Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
Entry Version
PARKINSON DIS SECOND
Entry Term(s)
Atherosclerotic Parkinsonism
Parkinson Disease, Secondary Vascular
Parkinson Disease, Symptomatic
Parkinsonism, Secondary
Parkinsonism, Symptomatic
Secondary Parkinsonism
Secondary Vascular Parkinson Disease
Symptomatic Parkinson Disease
NLM Classification #
WL 359
Previous Indexing
Parkinson Disease (1966-1972)
Public MeSH Note
2000; see PARKINSON DISEASE, SYMPTOMATIC 1979-1999, see PARKINSONISM, SYMPTOMATIC 1973-1978
Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)